Ward De Spiegelaere
- Molecular Biology top 10%
- Virology top 1%
- Infectious Diseases top 5%
- Immunology top 10%
- Cancer Research top 10%
- Co-authors
- Linos VandekerckhoveMaja KiselinovaWim TrypsteenEva MalatinkováWim Van Den BroeckPieter CornillieChristophe CasteleynMahtab Bahramsoltani
- Topics
- HIV Research and Treatment (36 papers)HIV/AIDS drug development and treatment (28 papers)HIV/AIDS Research and Interventions (20 papers)
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
Ward De Spiegelaere
105 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 140
- Molecular Biology 947
- Virology 610
- Infectious Diseases 532
- Immunology 270
- Cancer Research 255
Countries citing papers authored by Ward De Spiegelaere
This map shows the geographic impact of Ward De Spiegelaere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ward De Spiegelaere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ward De Spiegelaere more than expected).
Fields of papers citing papers by Ward De Spiegelaere
This network shows the impact of papers produced by Ward De Spiegelaere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ward De Spiegelaere. The network helps show where Ward De Spiegelaere may publish in the future.
Co-authorship network of co-authors of Ward De Spiegelaere
This figure shows the co-authorship network connecting the top 25 collaborators of Ward De Spiegelaere. A scholar is included among the top collaborators of Ward De Spiegelaere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ward De Spiegelaere. Ward De Spiegelaere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 6 | |
| 7 | 11 | |
| 8 | 7 | |
| 9 | 3 | |
| 10 | 13 | |
| 11 | 55 | |
| 12 | 1 | |
| 13 | 23 | |
| 14 | 69 | |
| 15 | Long-term early antiretroviral therapy limits the HIV-1 reservoir size as compared to later treatment initiation but not to levels found in long-term non-progressors | 1 |
| 16 | Aviremia 10-year post-ART discontinuation initiated at seroconversion | 0 |
| 17 | 49 | |
| 18 | 10 | |
| 19 | 9 | |
| 20 | 15 |
About Ward De Spiegelaere
Ward De Spiegelaere is a scholar working on Virology, Infectious Diseases and Immunology and Allergy, having authored 111 papers that have together received 2.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (36 papers), HIV/AIDS drug development and treatment (28 papers) and HIV/AIDS Research and Interventions (20 papers). The work is most often cited by research in Virology (610 citations), Infectious Diseases (532 citations) and Cancer Research (255 citations). Ward De Spiegelaere has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Linos Vandekerckhove, Maja Kiselinova, Wim Trypsteen, Eva Malatinková, Wim Van Den Broeck, Pieter Cornillie, Christophe Casteleyn, Mahtab Bahramsoltani, Johanna Plendl and Paul Simoens. Their work appears in journals such as PLoS ONE, Analytical Biochemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.